These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment. Suzuki Y; Remington JS Res Immunol; 1993 Jan; 144(1):66-7. PubMed ID: 8451522 [No Abstract] [Full Text] [Related]
5. Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis. Suzuki Y Immunobiology; 1999 Dec; 201(2):255-71. PubMed ID: 10631575 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Potasman I; Resnick L; Luft BJ; Remington JS Ann Intern Med; 1988 Jan; 108(1):49-51. PubMed ID: 3337515 [TBL] [Abstract][Full Text] [Related]
8. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. Eggers C; Gross U; Klinker H; Schalke B; Stellbrink HJ; Kunze K J Neurol; 1995 Oct; 242(10):644-9. PubMed ID: 8568525 [TBL] [Abstract][Full Text] [Related]
9. Evolution of cytokine profile during the treatment of cerebral toxoplasmosis in HIV-infected patients. Meira Cda S; Pereira-Chioccola VL; Vidal JE; Motoie G; Costa-Silva TA; Gava R; J Immunol Methods; 2015 Nov; 426():14-8. PubMed ID: 26177476 [TBL] [Abstract][Full Text] [Related]
10. Biology of Toxoplasma gondii. Wong SY; Remington JS AIDS; 1993 Mar; 7(3):299-316. PubMed ID: 8471191 [TBL] [Abstract][Full Text] [Related]
11. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice. Schlüter D; Deckert-Schlüter M; Schwendemann G; Brunner H; Hof H Immunology; 1993 Mar; 78(3):430-5. PubMed ID: 8478025 [TBL] [Abstract][Full Text] [Related]
12. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148 [TBL] [Abstract][Full Text] [Related]
13. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Gómez Marín JE; Pinon JM; Bonhomme A; Guenounou M Med Hypotheses; 1997 Feb; 48(2):161-9. PubMed ID: 9076698 [TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: an AIDS enhancing cofactor. Lin DS; Bowman DD Med Hypotheses; 1992 Oct; 39(2):140-2. PubMed ID: 1334211 [TBL] [Abstract][Full Text] [Related]
15. Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis. McHugh TD; Bathgate T; Mangan J; Johnson JD; Holliman RE; Butcher PD J Med Microbiol; 1997 Jul; 46(7):587-95. PubMed ID: 9236743 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478 [TBL] [Abstract][Full Text] [Related]
17. TGF-β in Toxoplasmosis: Friend or foe? Zare-Bidaki M; Assar S; Hakimi H; Abdollahi SH; Nosratabadi R; Kennedy D; Arababadi MK Cytokine; 2016 Oct; 86():29-35. PubMed ID: 27449809 [TBL] [Abstract][Full Text] [Related]